Denali Therapeutics Inc DNLI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:19 PM EDT
63.46quote price arrow down-1.08 (-1.68%)
Volume
187,566
52 week range
22.36 - 93.94

...

Loading . . .
  • Open64.73
  • Day High65.27
  • Day Low62.27
  • Prev Close64.54
  • 52 Week High93.94
  • 52 Week High Date12/22/20
  • 52 Week Low22.36
  • 52 Week Low Date07/24/20

Key Stats

  • Market Cap7.69B
  • Shares Out121.19M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta1.91
  • YTD % Change-24.49

KEY STATS

  • Open64.73
  • Day High65.27
  • Day Low62.27
  • Prev Close64.54
  • 52 Week High93.94
  • 52 Week High Date12/22/20
  • 52 Week Low22.36
  • 52 Week Low Date07/24/20
  • Market Cap7.69B
  • Shares Out121.19M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta1.91
  • YTD % Change-24.49

RATIOS/PROFITABILITY

  • EPS (TTM)0.13
  • P/E (TTM)470.39
  • Fwd P/E (NTM)-34.24
  • EBITDA (MRQ)59.995M
  • ROE (MRQ)7.01%
  • Revenue (MRQ)339.98M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)17.02%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Denali Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Denali Therapeutics Inc. is a biotechnology company. The Company is focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS) and others. The Company is developing a diversified portfolio of therapeutics, based on scientific insights into the genetic causes and biological processes underlying neurodegenerative disease. The Company has selected...
Vicki Sato Ph.D.
Non-Executive Chairman
Ryan Watts Ph.D.
President
Alexander Schuth M.D.
Chief Operating Officer
Steve Krognes
Chief Financial Officer
Address
161 Oyster Point Blvd
South San Francisco, CA
94080-1910
United States

Top Peers

SYMBOLLASTCHG%CHG
HALO
Halozyme Therapeutics Inc
43.34+0.87+2.05%
RARE
Ultragenyx Pharmaceutical Inc
82.43-1.12-1.34%
NVTA
Invitae Corp
28.07-0.33-1.18%
BHVN
Biohaven Pharmaceutical Holding Company Ltd
125.32+2.40+1.95%
XLRN
Acceleron Pharma Inc
123.50+1.29+1.06%